Elevated CAMP Protects Against Diclofenac-Induced Toxicity in Primary Rat Hepatocytes: A Protective Effect Mediated by the Exchange Protein Directly Activated by CAMP/cAMP-Regulated Guanine Nucleotide Exchange Factors

Overview

Journal Mol Pharmacol

Specialties Molecular Biology
Pharmacology

Date 2021 Feb 12

PMID 33574047

Citations 1

Authors

Fabio Alejandro Aguilar Mora

Nshunge Musheshe

Asmaa Oun

Manon Buist-Homan

Frank Lezoualch

Xiaodong Cheng

Martina Schmidt

Han Moshage

Affiliations

Soon will be listed here.

Abstract

Chronic consumption of the nonsteroidal anti-inflammatory drug diclofenac may induce drug-induced liver injury (DILI). The mechanism of diclofenac-induced liver injury is partially elucidated and involves mitochondrial damage. Elevated cAMP protects hepatocytes against bile acid-induced injury. However, it is unknown whether cAMP protects against DILI and, if so, which downstream targets of cAMP are implicated in the protective mechanism, including the classic protein kinase A (PKA) pathway or alternative pathways like the exchange protein directly activated by cAMP (EPAC). The aim of this study was to investigate whether cAMP and/or its downstream targets protect against diclofenac-induced injury in hepatocytes. Rat hepatocytes were exposed to 400 µmol/l diclofenac. Apoptosis and necrosis were measured by caspase-3 activity assay and Sytox green staining, respectively. Mitochondrial membrane potential (MMP) was measured by JC-10 staining. mRNA and protein expression were assessed by quantitative polymerase chain reaction (qPCR) and Western blot, respectively. The cAMP-elevating agent 7-acetoxy-8,13-epoxy-1,6,9-trihydroxylabd-14-en-11-one (forskolin), the pan-phosphodiesterase inhibitor IBMX, and EPAC inhibitors 5,7-dibromo-6-fluoro-3,4-dihydro-2-methyl-1(2H)-quinoline carboxaldehyde (CE3F4 and ESI-O5 were used to assess the role of cAMP and its effectors, PKA or EPAC. Diclofenac exposure induced apoptotic cell death and loss of MMP in hepatocytes. Both forskolin and IBMX prevented diclofenac-induced apoptosis. EPAC inhibition but not PKA inhibition abolished the protective effect of forskolin and IBMX. Forskolin and IBMX preserved the MMP, whereas both EPAC inhibitors diminished this effect. Both EPAC1 and EPAC2 were expressed in hepatocytes and localized in mitochondria. cAMP elevation protects hepatocytes against diclofenac-induced cell death, a process primarily involving EPACs. The cAMP/EPAC pathway may be a novel target for treatment of DILI. SIGNIFICANCE STATEMENT: This study shows two main highlights. First, elevated cAMP levels protect against diclofenac-induced apoptosis in primary hepatocytes via maintenance of mitochondrial integrity. In addition, this study proposes the existence of mitochondrial cAMP-EPAC microdomains in rat hepatocytes, opening new avenues for targeted therapy in drug-induced liver injury (DILI). Both EPAC1 and EPAC2, but not protein kinase A, are responsible for this protective effect. Our findings present cAMP-EPAC as a potential target for the treatment of DILI and liver injury involving mitochondrial dysfunction.

Citing Articles

The role of exosomal lncRNAs in acetaminophen-induced induced liver injury in SD rats.

Yang Z, Shi L, Zheng M, Hou M, Zhou M, Su N Noncoding RNA Res. 2024; 9(4):1190-1202.

PMID: 39026604 PMC: 11254842. DOI: 10.1016/j.ncrna.2024.05.011.

References

Hoivik E, Witsoe S, Bergheim I, Xu Y, Jakobsson I, Tengholm A . DNA methylation of alternative promoters directs tissue specific expression of Epac2 isoforms. PLoS One. 2013; 8(7):e67925. PMC: 3701594. DOI: 10.1371/journal.pone.0067925. View

Sivertsen Asrud K, Pedersen L, Aesoy R, Muwonge H, Aasebo E, Pettersen I . Mice depleted for Exchange Proteins Directly Activated by cAMP (Epac) exhibit irregular liver regeneration in response to partial hepatectomy. Sci Rep. 2019; 9(1):13789. PMC: 6760117. DOI: 10.1038/s41598-019-50219-8. View

Masubuchi Y, Nakayama S, Horie T . Role of mitochondrial permeability transition in diclofenac-induced hepatocyte injury in rats. Hepatology. 2002; 35(3):544-51. DOI: 10.1053/jhep.2002.31871. View

Moshage H, Casini A, Lieber C . Acetaldehyde selectively stimulates collagen production in cultured rat liver fat-storing cells but not in hepatocytes. Hepatology. 1990; 12(3 Pt 1):511-8. DOI: 10.1002/hep.1840120311. View

Liu D, Wang Z, Nicolas V, Lindner M, Mika D, Vandecasteele G . PDE2 regulates membrane potential, respiration and permeability transition of rodent subsarcolemmal cardiac mitochondria. Mitochondrion. 2019; 47:64-75. DOI: 10.1016/j.mito.2019.05.002. View

Lores Arnaiz S, Llesuy S, Cutrin J, Boveris A . Oxidative stress by acute acetaminophen administration in mouse liver. Free Radic Biol Med. 1995; 19(3):303-10. DOI: 10.1016/0891-5849(95)00023-q. View

Laudette M, Coluccia A, Sainte-Marie Y, Solari A, Fazal L, Sicard P . Identification of a pharmacological inhibitor of Epac1 that protects the heart against acute and chronic models of cardiac stress. Cardiovasc Res. 2019; 115(12):1766-1777. DOI: 10.1093/cvr/cvz076. View

Aithal G, Day C . Nonsteroidal anti-inflammatory drug-induced hepatotoxicity. Clin Liver Dis. 2007; 11(3):563-75, vi-vii. DOI: 10.1016/j.cld.2007.06.004. View

Gan T . Diclofenac: an update on its mechanism of action and safety profile. Curr Med Res Opin. 2010; 26(7):1715-31. DOI: 10.1185/03007995.2010.486301. View

10.

Honrath B, Matschke L, Meyer T, Magerhans L, Perocchi F, Ganjam G . SK2 channels regulate mitochondrial respiration and mitochondrial Ca uptake. Cell Death Differ. 2017; 24(5):761-773. PMC: 5423111. DOI: 10.1038/cdd.2017.2. View

11.

Schippers M, Beljaars L, Post E, Lotersztajn S, Reker-Smit C, Han B . Upregulation of Epac-1 in Hepatic Stellate Cells by Prostaglandin E in Liver Fibrosis Is Associated with Reduced Fibrogenesis. J Pharmacol Exp Ther. 2017; 363(2):126-135. DOI: 10.1124/jpet.117.241646. View

12.

Santos-Alves E, Marques-Aleixo I, Coxito P, Balca M, Rizo-Roca D, Rocha-Rodrigues S . Exercise mitigates diclofenac-induced liver mitochondrial dysfunction. Eur J Clin Invest. 2014; 44(7):668-77. DOI: 10.1111/eci.12285. View

13.

Conde de la Rosa L, Schoemaker M, Vrenken T, Buist-Homan M, Havinga R, Jansen P . Superoxide anions and hydrogen peroxide induce hepatocyte death by different mechanisms: involvement of JNK and ERK MAP kinases. J Hepatol. 2005; 44(5):918-29. DOI: 10.1016/j.jhep.2005.07.034. View

14.

Syed M, Skonberg C, Hansen S . Mitochondrial toxicity of diclofenac and its metabolites via inhibition of oxidative phosphorylation (ATP synthesis) in rat liver mitochondria: Possible role in drug induced liver injury (DILI). Toxicol In Vitro. 2015; 31:93-102. DOI: 10.1016/j.tiv.2015.11.020. View

15.

Insel P, Zhang L, Murray F, Yokouchi H, Zambon A . Cyclic AMP is both a pro-apoptotic and anti-apoptotic second messenger. Acta Physiol (Oxf). 2011; 204(2):277-87. PMC: 3125423. DOI: 10.1111/j.1748-1716.2011.02273.x. View

16.

Courilleau D, Bouyssou P, Fischmeister R, Lezoualch F, Blondeau J . The (R)-enantiomer of CE3F4 is a preferential inhibitor of human exchange protein directly activated by cyclic AMP isoform 1 (Epac1). Biochem Biophys Res Commun. 2013; 440(3):443-8. DOI: 10.1016/j.bbrc.2013.09.107. View

17.

Wiggins S, Steegborn C, Levin L, Buck J . Pharmacological modulation of the CO/HCO/pH-, calcium-, and ATP-sensing soluble adenylyl cyclase. Pharmacol Ther. 2018; 190:173-186. PMC: 6484840. DOI: 10.1016/j.pharmthera.2018.05.008. View

18.

Perry S, Norman J, Barbieri J, Brown E, Gelbard H . Mitochondrial membrane potential probes and the proton gradient: a practical usage guide. Biotechniques. 2011; 50(2):98-115. PMC: 3115691. DOI: 10.2144/000113610. View

19.

Wang Z, Liu D, Varin A, Nicolas V, Courilleau D, Mateo P . A cardiac mitochondrial cAMP signaling pathway regulates calcium accumulation, permeability transition and cell death. Cell Death Dis. 2016; 7:e2198. PMC: 4855650. DOI: 10.1038/cddis.2016.106. View

20.

Lakics V, Karran E, Boess F . Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues. Neuropharmacology. 2010; 59(6):367-74. DOI: 10.1016/j.neuropharm.2010.05.004. View